|
Volumn 23, Issue 5, 2003, Pages 1333-1339
|
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
GLUTAMATE CYSTEINE LIGASE;
GLUTATHIONE;
MESSENGER RNA;
PROTEIN P53;
RIBOZYME;
ARTICLE;
CELL SURVIVAL;
CHEMISTRY;
CONFORMATION;
DOSE RESPONSE;
DRUG RESISTANCE;
ENZYME ACTIVE SITE;
HUMAN;
IMMUNOBLOTTING;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METABOLISM;
MOLECULAR GENETICS;
NORTHERN BLOTTING;
NUCLEOTIDE SEQUENCE;
PATHOLOGY;
PLASMID;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
BASE SEQUENCE;
BLOTTING, NORTHERN;
CARCINOMA, NON-SMALL-CELL LUNG;
CATALYTIC DOMAIN;
CELL LINE, TUMOR;
CELL SURVIVAL;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, NEOPLASM;
GLUTAMATE-CYSTEINE LIGASE;
GLUTATHIONE;
HUMANS;
IMMUNOBLOTTING;
LUNG NEOPLASMS;
MOLECULAR SEQUENCE DATA;
NUCLEIC ACID CONFORMATION;
PLASMIDS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, CATALYTIC;
RNA, MESSENGER;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
EID: 3142681189
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.23.5.1333 Document Type: Article |
Times cited : (16)
|
References (0)
|